NITROGLYCERIN SUMMARY
NITROGLYCERIN TRANSDERMAL SYSTEM
0.1, 0.2, 0.4 and 0.6 mg/hr
FOR INTRAVENOUS USE ONLY. NOT FOR DIRECT INTRAVENOUS INJECTION. NITROGLYCERIN INJECTION, USP MUST BE DILUTED IN 5% DEXTROSE INJECTION, USP, OR 0.9% SODIUM CHLORIDE INJECTION, USP PRIOR TO ITS INFUSION (SEE DOSAGE AND ADMINISTRATION SECTION). THE ADMINISTRATION SET USED FOR INFUSION WILL AFFECT THE AMOUNT OF NITROGLYCERIN DELIVERED TO THE PATIENT (SEE WARNINGS, AND DOSAGE AND ADMINISTRATION SECTIONS).
CAUTION: SEVERAL PREPARATIONS OF NITROGLYCERIN FOR INJECTION ARE AVAILABLE. THEY DIFFER IN CONCENTRATION AND/OR VOLUME PER VIAL. WHEN SWITCHING FROM ONE PRODUCT TO ANOTHER ATTENTION MUST BE PAID TO THE DILUTION AND DOSAGE AND ADMINISTRATION INSTRUCTIONS.
Nitroglycerin is 1,2,3-propanetriol trinitrate, an organic nitrate.
Nitroglycerin Injection, USP is indicated for treatment of perioperative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and β-blockers; and for induction of intraoperative hypotension.
|
